• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Past, present, and future surgical management of malignant epithelial neoplasms of the lacrimal gland.

作者信息

Henderson J W

出版信息

Br J Ophthalmol. 1986 Oct;70(10):727-31. doi: 10.1136/bjo.70.10.727.

DOI:10.1136/bjo.70.10.727
PMID:3022787
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1040816/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d86b/1040816/22321ab070df/brjopthal00130-0014-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d86b/1040816/22321ab070df/brjopthal00130-0014-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d86b/1040816/22321ab070df/brjopthal00130-0014-a.jpg

相似文献

1
Past, present, and future surgical management of malignant epithelial neoplasms of the lacrimal gland.泪腺恶性上皮性肿瘤的过去、现在及未来手术治疗
Br J Ophthalmol. 1986 Oct;70(10):727-31. doi: 10.1136/bjo.70.10.727.
2
Adenoid cystic carcinoma of the lacrimal gland, is there a cure?泪腺腺样囊性癌，有治愈的可能吗？
Trans Am Ophthalmol Soc. 1987;85:312-9.
3
Factors affecting the survival of patients with lacrimal gland tumours.影响泪腺肿瘤患者生存的因素。
Can J Ophthalmol. 1982 Feb;17(1):3-9.
4
Management of lacrimal fossa masses.泪囊窝肿物的管理
Arch Otolaryngol Head Neck Surg. 1986 Feb;112(2):164-7. doi: 10.1001/archotol.1986.03780020044010.
5
Simultaneous diagnosis of ipsilateral adenoid cystic carcinoma of the lacrimal gland and orbital cavernous hemangioma: case report.泪腺腺样囊性癌与眼眶海绵状血管瘤同侧同时诊断：病例报告
Orbit. 2014 Aug;33(4):283-5. doi: 10.3109/01676830.2013.842254. Epub 2014 Apr 30.
6
[Adenoid cystic carcinoma of the lacrimal gland: report of two cases and literature review].[泪腺腺样囊性癌：2例报告及文献复习]
Klin Monbl Augenheilkd. 2011 Jan;228(1):54-6. doi: 10.1055/s-0029-1245777. Epub 2010 Dec 3.
7
Surgical approaches to orbital lesions.眼眶病变的手术入路。
Trans New Orleans Acad Ophthalmol. 1982;30:150-67.
8
Orbitocranial approach for treatment of adenoid cystic carcinoma of the lacrimal gland.眶颅入路治疗泪腺腺样囊性癌
Ann Otol Rhinol Laryngol. 2011 Jun;120(6):397-400. doi: 10.1177/000348941112000609.
9
[ Ulcerated adenoid cystic carcinoma of the lacrimal gland--case presentation].[泪腺溃疡性腺样囊性癌——病例报告]
Oftalmologia. 2003;57(2):46-8.
10
Long-Term Outcomes of Eye-Sparing Surgery for Adenoid Cystic Carcinoma of Lacrimal Gland.泪腺腺样囊性癌保留眼球手术的长期预后
Ophthalmic Plast Reconstr Surg. 2018 Jan/Feb;34(1):74-78. doi: 10.1097/IOP.0000000000000877.

引用本文的文献

1
Neoadjuvant Intra-Arterial Cytoreductive Chemotherapy for Lacrimal Gland Adenoid Cystic Carcinoma: A Long-Term Follow-up Study of a Trimodal Strategy.新辅助动脉内细胞减灭化疗治疗泪腺腺样囊性癌：三联治疗策略的长期随访研究。
Am J Ophthalmol. 2022 Aug;240:239-251. doi: 10.1016/j.ajo.2022.03.027. Epub 2022 Apr 2.
2
Clinical and microdissection genotyping analyses of the effect of intra-arterial cytoreductive chemotherapy in the treatment of lacrimal gland adenoid cystic carcinoma.动脉内减瘤化疗治疗泪腺腺样囊性癌效果的临床及显微切割基因分型分析
Trans Am Ophthalmol Soc. 2005;103:337-67.

本文引用的文献

1
BONE RESECTION IN THE EXCISION OF EPITHELIAL TUMORS OF THE LACRIMAL GLAND.
Arch Ophthalmol. 1964 Mar;71:382-5. doi: 10.1001/archopht.1964.00970010398016.
2
Epithelial lacrimal gland tumors: pathology as a guide to prognosis.
Trans Am Acad Ophthalmol Otolaryngol. 1954 Nov-Dec;58(6):848-66.
3
Factors affecting the survival of patients with lacrimal gland tumours.影响泪腺肿瘤患者生存的因素。
Can J Ophthalmol. 1982 Feb;17(1):3-9.
4
Regional cranio-orbital resection for recurrent tumors with delayed reconstruction.
复发性肿瘤的区域颅眶切除术及延迟重建
Surg Gynecol Obstet. 1972 Mar;134(3):437-47.
5
En bloc removal of intrinsic neoplasms of the lacrimal gland.泪腺原发性肿瘤的整块切除。
Trans Am Ophthalmol Soc. 1976;74:133-43.
6
Combined therapeutic approach to malignant lacrimal gland tumors.恶性泪腺肿瘤的联合治疗方法
Am J Ophthalmol. 1975 Jan;79(1):53-5. doi: 10.1016/0002-9394(75)90455-9.